Tower Research Capital LLC (Trc) Tango Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 14,765 shares of TNGX stock, worth $44,885. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,765
Previous 15,682
5.85%
Holding current value
$44,885
Previous $134,000
15.67%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding TNGX
# of Institutions
126Shares Held
91.8MCall Options Held
3.1KPut Options Held
1.5K-
Trv Gp Iv, LLC Boston, MA16.9MShares$51.3 Million80.09% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA13.3MShares$40.5 Million4.45% of portfolio
-
Boxer Capital, LLC San Diego, CA8.2MShares$24.9 Million3.35% of portfolio
-
Nextech Invest Ag5.53MShares$16.8 Million6.95% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.02MShares$15.3 Million0.02% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $268M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...